Voltage-gated calcium channel beta subunit (Cavβ)

The voltage-gated calcium channel beta subunit (Cavβ) is a critical cytosolic auxiliary component of high-voltage-activated (HVA) calcium channels, including L-type, P/Q-type, N-type, and R-type channels (Buraei & Yang, 2010). It functions primarily as a molecular chaperone, facilitating the trafficking of the pore-forming alpha-1 subunit from the endoplasmic reticulum to the plasma membrane, which is essential for functional channel expression (UniProt). Additionally, Cavβ subunits significantly modulate the biophysical properties of these channels, such as shifting the voltage dependence of activation and accelerating the kinetics of inactivation (NCBI Gene). There are four known isoforms (Cavβ1–Cavβ4), each encoded by a different CACNB gene and exhibiting distinct tissue-specific expression patterns in the heart, brain, and skeletal muscle. Mutations in these subunits are linked to several channelopathies, most notably Brugada syndrome (CACNB2) and juvenile myoclonic epilepsy or episodic ataxia (CACNB4) (PubMed). While no FDA-approved drugs currently target the beta subunit directly, it is an area of active research for developing novel therapeutics for cardiovascular and neurological disorders by disrupting the alpha-beta subunit interaction.

Other names

Calcium channel voltage-dependent subunit betaCACNB familyCABCACBCavB

Modulation of the pore-forming alpha-1 subunit to increase surface expression and alter channel opening/closing kinetics.